Latest Blogs

Feb 23, 2021
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
Feb 18, 2021
This is a time of significant and multi-layered anxiety, especially for our patients living with and beyond cancer. 
Feb 11, 2021
"My motto is to stand up for all the people who face casual racism, sexism, and injustice, and my aim is to protect international trainees in medicine when it is my turn to be a mentor," Dr. Viju Chandrasekhar affirms as she shares a personal experience with bias based on her accent.
Feb 11, 2021
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jun 29, 2018
At the most recent Board of Directors meeting, we heard insightful presentations from participants in the Leadership Development Program, pivoted toward the execution of our 5-year strategic plan, and had a valuable conversation with NCI director Dr. Norman Sharpless.
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 17, 2018
ASCO would like to inform you of some changes to MOC that are a direct result of your input and our open, transparent collaboration with the ABIM. 
May 08, 2018
We examine how state-level health care policy may impact the care that we deliver to our patients with cancer, and why it's important for us to pay attention to and help shape bills and regulations moving in states.
Apr 06, 2018
Our vice president of Clinical Affairs breaks down the reporting changes you need to understand and address to avoid potential financial penalties in 2020.
Mar 30, 2018
The decisions the Board made will enable ASCO to define the behaviors and resources that support our professional community to achieve greater career satisfaction while delivering ever better care.

Pages